MEDITE Signs OEM Agreement With a Leading Anatomical Pathology Company
April 23 2014 - 7:00AM
Marketwired
MEDITE Signs OEM Agreement With a Leading Anatomical Pathology
Company
ORLANDO, FL--(Marketwired - Apr 23, 2014) - MEDITE Group, a
leading developer and manufacturer of innovative, high-quality
equipment and supplies for histology, pathology and cytology
laboratories, has signed an OEM agreement with a leading anatomical
pathology company to distribute MEDITE's proprietary high
transparency coverslipping film to be used in all Tape-Coverslipper
machines. MEDITE's branded CytoTape is manufactured in Germany
and was commercially launched in 2013. It was specifically designed
for perfect optical characteristics, long durability and the
ability to withstand higher temperatures. Tape-Coverslippers can
process up to 1,200 microscopic slides per hour compared to up to
400 slides per hour for standard glass coverslippers, a key
advantage for high volume labs in the cancer diagnostic segments of
cytology and histology.
Under the terms of the agreement, this leading anatomical
pathology company will have exclusive rights to market, sell and
distribute MEDITE's coverslipping film as an OEM product in the
U.S. and Canada. MEDITE anticipates this agreement, along with
the positive response to CytoTape experienced in other global
markets, will be a significant contributor to the Company's revenue
growth in 2014. The Company did not report meaningful revenue from
CytoTape in 2013 as it was launched late in the year.
"After significant investments into the development of
innovative new products in previous years, the focus for the past
year has been developing new sales channels primarily in the North
American market for our products," commented Michaela Ott, Chief
Executive Officer of CytoCore (Ms. Ott was Co-President and CEO of
MEDITE prior to the recent acquisition with
CytoCore). "Reflecting our innovative heritage as a
manufacturer of quality products that are highly valued by leading
laboratory companies, CytoTape is an outstanding product with
features preferred by high-volume labs, such as accelerated
adhesiveness and cost effectiveness. It is being used by labs
globally and based on the market's acceptance and positive feedback
along with today's announcement; we believe it could become a
standard for every lab that uses Tape-Coverslippers."
On April 3, 2014, MEDITE completed an acquisition transaction
with CytoCore, Inc. (OTCBB: CYOE). The Company is positioned
to emerge as a rapidly growing disruptive force in the
multi-billion dollar global histology and cytology systems
marketplace for cancer detection.
About MEDITE/CytoCore The Holding MEDITE Enterprise Inc.,
Orlando, wholly-own Medite GmbH a Germany-based Company with its
subsidiaries CytoGlobe GmbH (Cytology Products, Germany), Medite
GmbH (Distributor, Austria), Medite Inc. (Distributor, Americas).
Since 1978, MEDITE® Group has specialized on the development,
manufacture and distribution of medical laboratory automation
equipment and supplies for pathology, histology and cytology. For
these fields, the Company offers a complete range of devices and
consumables. MEDITE Group currently sells into 70 countries
and is the market leader in Germany. Through CytoGlobe, a wholly
owned subsidiary, MEDITE offers a full range of products for
Cytology labs. Additional information on MEDITE's products and
services can be found at www.medite-group.com. CytoCore®, Inc. is a
biomolecular diagnostics company engaged in the design,
development, and commercialization of cost-effective cancer
screening systems and Biomarkers to assist in the early detection
of cancer.
Contact Information: EVC Group Investor Contact: Doug Sherk
415-652-9100 Michael Polyviou 212-850-6020 Media Contact: Janine
McCargo 646-688-0425
Himalaya Technologies (PK) (USOTC:HMLA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Himalaya Technologies (PK) (USOTC:HMLA)
Historical Stock Chart
From Apr 2023 to Apr 2024